Keros Therapeutics, Inc. (KROS)
17.91
-0.08
(-0.44%)
USD |
NASDAQ |
Jan 30, 16:00
17.88
-0.03
(-0.17%)
After-Hours: 20:00
Keros Therapeutics EPS Diluted (Quarterly) : -0.1792 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| MannKind Corp. | 0.0256 |
| Sarepta Therapeutics, Inc. | -1.795 |
| Insmed, Inc. | -1.747 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.28M |
| Revenue (Quarterly) | 14.26M |
| Total Expenses (Quarterly) | 21.54M |
| Enterprise Value | -130.40M |
| Gross Profit Margin (Quarterly) | 97.23% |
| Profit Margin (Quarterly) | -51.04% |
| Earnings Yield | 8.61% |
| Operating Earnings Yield | 5.99% |
| Normalized Earnings Yield | 8.615 |